XML 75 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER COMMON SHARE
9 Months Ended
Sep. 30, 2013
Notes to Financial Statements [Abstract]  
EARNINGS PER COMMON SHARE
EARNINGS PER COMMON SHARE

The dilutive effect of outstanding non-qualified stock options and RSU is reflected in diluted earnings per share by application of the treasury stock method. The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September 30, 2013 and 2012:

Basic Earnings Per Common Share Computation
Three Months Ended
 
Nine Months Ended
(in thousands, except per share amounts)
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
Net income attributable to DENTSPLY International
$
79,851

 
$
53,364

 
$
238,763

 
$
187,413

 
 
 
 
 
 
 
 
Weighted average common shares outstanding
142,421

 
141,843

 
142,705

 
141,767

 
 
 
 
 
 
 
 
Earnings per common share - basic
$
0.56

 
$
0.38

 
$
1.67

 
$
1.32

 
 
 
 
 
 
 
 
Diluted Earnings Per Common Share Computation
 

 
 

 
 

 
 

(in thousands, except per share amounts)
 

 
 

 
 

 
 

 
 
 
 
 
 
 
 
Net income attributable to DENTSPLY International
$
79,851

 
$
53,364

 
$
238,763

 
$
187,413

 
 
 
 
 
 
 
 
Weighted average common shares outstanding
142,421

 
141,843

 
142,705

 
141,767

Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards
2,277

 
2,041

 
2,247

 
2,118

Total weighted average diluted shares outstanding
144,698

 
143,884

 
144,952

 
143,885

 
 
 
 
 
 
 
 
Earnings per common share - diluted
$
0.55

 
$
0.37

 
$
1.65

 
$
1.30



Options to purchase 2.1 million and 2.7 million shares of common stock that were outstanding during the three and nine months ended September 30, 2013, respectively, were not included in the computation of diluted earnings per common share since the options’ exercise price were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. There were 3.8 million and 4.1 million antidilutive shares of common stock outstanding during the three and nine months ended September 30, 2012, respectively.